The question of effects of long-term melatonin (MEL) administration have not yet been explained sufficiently, especially its metabolic consequences in young persons and animals. The aim of the present study was to analyze the effects of MEL given during prolonged time (for 3 months) and chronically (for 6 months) at the dose of 4 µg/mL of tap water, on the selected metabolic and hormonal parameters in young female and male Wistar:Han (WH) rats. The weights of selected organs, tissues, body weight gains and food and water intake were registered. Six weeks aged rats were adapted to standard housing conditions and light regimen L:D=12:12 h, fed standard laboratory diet and drank tap water (controls) or MEL solution ad libitum; finally they were sacrificed after overnight fasting. Prolonged MEL administration decreased serum glucose concentration and increased triacylglycerol and malondialdehyde concentration/content in the liver in females. In males MEL increased concentrations of serum phospholipids, corticosterone and liver malondialdehyde. MEL treatment reduced the body weight in both sexes and weight of epididymal fat in males, without any alterations of food and water intake. Chronic MEL administration reduced serum glucose concentration and increased concentration/content of glycogen, triacylglycerol and cholesterol in the liver and glycogen concentration/content in heart muscle in males. In females, the significant rise of serum corticosterone concentration and liver malondialdehyde content was recorded. MEL significantly increased liver weight and decreased thymus weight in males. MEL administration increased temporarily water intake in males, body and epididymal fat weights were similar to that in controls. Body weight of MEL drinking females was reduced in the 1 st half of experiment only; the food and water intake did not differ from control group. The response in WH rats on MEL was more prominent as in the Sprague-Dawley strain (our previous studies). Male rats were generally more affected, probably due to higher daily and total consumption of melatonin.
Introduction
Pleiotropic effect of melatonin (MEL) is well-known. The existence of MEL receptors and high-afinity binding sites of MEL in many peripheral tissues indicates that MEL affects these tissues directly and regulates physiological functions (Pang et al., 1993) . Data about the effects of long-term melatonin treatment are not sufficient, especially from the metabolic point of view. It was demonstrated that MEL is involved in hepatic metabolic processes, influences the activities of many enzymes (Popov et al., 1990; Walsh et al., 1994) and is also involved in the lipid and carbohydrate metabolism (Mori et al., 1989) . Moreover, MEL protects the liver from oxidative damage (Sewerynek et al., 1996) .
The question of mechanism by which MEL influ-ences various metabolic processes, is still opened. Concerning the carbohydrate metabolism, hyper-and hypoglycemic effects of MEL were found in experimental animals after pinealectomy and after the exogenous MEL treatment. It was documented that pinealectomy induced hyperglycemia (Rodriguez et al., 1989) or hypoglycemia (Gorray et al., 1979) and exogenous MEL administration increases (Dhar et al., 1983) , decreases (Mahata et al., 1988) or have no influence on the blood glucose level (John et al., 1990) . Mechanism, which is involved in modulation of the plasma glucose by MEL, remains unknown. It is assumed that MEL can act indirectly -through the other hormones involved in carbohydrate metabolism, e.g., insulin, glucagon, growth hormone or catecholamines but results are inconsistent. It was demonstrated that MEL enhances the insulin level in plasma of pinealectomized rats (Diaz & Blazquez, 1986) , reduces insulin secretion from pancreatic islets cells in vitro (Peschke et al., 1997) or has no effect on pancreatic insulin release (Frankel & Strandberg, 1991) . MEL alters concentrations of insulin and glucagon receptors in the liver (Rodriguez et al., 1989) and enhances the catecholamines content in the adrenal medulla (Mahata et al., 1988) . Moreover, the existence of central site of MEL effects in the brain is assumed in the suprachiasmatic nucleus of hypothalamus (Shima et al., 1997) . In mammals, MEL can reduce the serum triacylglycerols and cholesterol levels (Hoyos et al., 2000) and has an inhibiting effect on absorption of plasma free fatty acids for lipogenesis and fasting-induced lipolysis in healthy rats (Sauer et al., 2001) . It was recorded that MEL has also anti-cholesterogenic effects (Damian, 1976) . MEL administration to the diabetic rats decreases hyperlipidemia, hyperinsulinemia and hyperleptinemia and improves the problems associated with diabetes mellitus of type II (Nishida et al., 2002) . Damian et al. (1979) recorded the increase of the plasma and liver cholesterol levels in pinealectomized rats in comparison to non-pinealectomized animals.
Because MEL is present not only in the central nervous system but also in gastrointestinal tract, it is probable that it plays a role in food intake. MEL effects on food intake are controversial. It was demonstrated that MEL administration decreased the food intake in rats (Ishibashi et al., 1966) , in domestic fowls (Bermudez et al., 1983) , in hamsters (Bartness & Wade, 1985) and in fishes (Pinillos et al., 2001) ; while the other authors does not found any effect of MEL on food intake in rats (Dark et al., 1980; Wolden-Hanson et al., 2000) . On the contrary, other studies in rodents reported the increase of food intake as a result of exogenous MEL administration (Bubenik & Pang, 1994; Shaji & Kulkarni, 1998) or melatonin agonist (Le Gouic et al., 1996) . MEL effect on food intake probably depends on the dose of MEL and on the time of its administration.
The present study is a follow-up research of the effect of low doses MEL administered during 3 and 6 months on metabolic and hormonal variables in young Sprague-Dawley (SD) rats of both sexes (Marková et al., 2003; . It is focused on metabolic effects of MEL administered for 3 and 6 months to young 6-weekold males and females of Wistar:Han (WH) rats including MEL effects on organ weights, intraabdominal white adipose tissue and body weight. We were interested also in the inter-sexual differences in reaction to the individual respective observed variables and in the comparison of reactibility of both SD and WH strains.
Methods
Male and female Wistar:Han (WH) rats (Faculty of Medici-ne, P.J. Šafárik University, Košice, Slovakia) aged 37-40 days, weighing 115-140 g were used in the experiment. The animals were adapted to standard housing conditions (temperature 23 ± 2 • C, relative humidity 60-70%) and artificial light:dark regimen LD 12:12, with lights on at 07.00 h, with intensity 150 lux per cage (TESLA, fluorescent lamps, 40 W). The rats were fed standard MP laboratory diet (Top-Dovo, Dobrá Voda, Slovakia), drank tap water and MEL solution, respectively, ad libitum. Four to five rats were housed per cage. Experiment was approved by the State Veterinary and Food Administration of the Slovak Republic by accreditation No 431/03-220.
MEL (Sigma, Diesenhofen, Germany) was administered in tap water at a concentration 4 µg/mL discontinuously -from 03.00 p.m. to 08.00 a.m. -in the period of increased sensitivity of the organism to MEL (from 08.00 a.m. to 03.00 p.m. the animals were drinking tap water) for period of 3 months and 6 months, respectively. Ten mg of MEL were dissolved in 0.2 mL of 30% ethanol and mixed up with tap water to the required concentration. The solution of MEL was freshly prepared three times a week. The bottles with MEL solution were covered with a dark foil. The drinking water of control group contained 0.01% ethanol.
The animals in both experiments were divided into 4 groups: females and males that were administered MEL (MEL-females, MEL-males; 14 animals in each group) and control females and males that were not treated with MEL (CONT-females, CONT-males; 14 animals in each group). The rats were weighed twice a week and once a month daily food and water intake was observed (a total of 5 measurements). Oral glucose tolerance tests (OGTTs) were carried out before MEL administration and 10 weeks thereafter in 3-month administration of MEL and 21 weeks thereafter in 6-month administration of MEL as follows: 1 g of glucose per 1 kg body weight in 20% solution was administered intragastrically to animals following overnight fasting. Twenty-five µL of the blood was collected from rat tail vein before glucose administration and 15, 30, 60 and 120 minutes after glucose load. Glucose concentration was determined enzymatically in the blood and presented as graphs. The OGTTs were evaluated by calculation of area under curve (AUC) according to the formula: AUC (mmol · h) = (G0 + 2G15 + 3G30 + 6G60 + 4G120)/8, where G0-G120 are the respective blood glucose values. After 3 and 6 months, respectively, following overnight fasting the animals were sacrificed by quick decapitation between 08.00 and 11.00 a.m.; selected organs (liver, heart muscle, spleen, thymus, adrenal glands) and white fat (periovarial and epididymal) were weighed and the selected parameters were determined in the serum, liver, heart muscle and bone marrow (femur):
-in the serum from mixed blood: concentration of glucose, triacylglycerols, total cholesterol, phospholipids, corticosterone and insulin; -in the liver: concentrations/contents of glycogen, triacylglycerols, total cholesterol, phospholipids, malondialdehyde (as an indicator of lipoperoxidation); -in the bone marrow: concentration of triacylglycerols, phospholipids and malondialdehyde; -in the heart muscle: glycogen concentration/content. Phospholipids were measured from lipid phosphorus according to BARTLETT (1959) , total cholesterol according to ZLATKIS et al. (1953) , glycogen according to ROE & DAI-LEY (1966), malondialdehyde was measured in reaction with thiobarbituric acid (SATCH, 1978), for triacylglycerols and glucose measurement commercial sets of Lachema (Brno, Czech Republic) were used, insulin by radioimmunoassay with the use of commercial set of Linco Research (St. Charles, MO, USA), corticosterone was measured using fluorimetry according to GUILLEMIN et al. (1958) . Results were statistically evaluated by one-way analysis of variance and Kruskal-Wallis test. The criterion for the choice of relevant test was the value of Bartlet's number. Data are presented as means ± standard error of the mean (S.E.M.) and significant differences between groups as: "a" for p ≤ 0.05, "b" for p ≤ 0.01, and "c" for p ≤ 0.001.
The experiment was carried out from May to October.
Results
The prolonged (3 months lasting) MEL administration significantly decreased serum glucose concentration, in-creased liver triacylglycerols and malondialdehyde concentration/content in females. In males, MEL significantly increased phospholipids and corticosterone concentrations in serum as well as malondialdehyde concentration in liver (Tab. 1). The weight of selected organs and tissues was not influenced in MEL treated females (Tab. 2). Three months lasting MEL administration decreased absolute weight of epididymal fat in males along with its body weight from 11 th day till the end of experiment (Tab. 2, Fig. 1) ; the other organs and tissues weight did not differ from controls. MEL decreased also the body weight of females from 15 th day of experiment (with a few exceptions) till the end of experiment; the periovarial fat weight was not changed (Tab. 2, Fig. 1 ).
Water intake in animals of both sexes drinking MEL did not differ from control animals during the whole experiment. Food intake was temporary decreased in MEL-females only in the 6 th week of experiment. In MEL-males food intake did not differ from the controls during experiment. The average daily food and water intake was higher in males in both groups than in females in both groups. An average daily MEL intake was 108.6 µg in females and 197.4 µg in males.
The average final body weight (g) in males of both groups was higher than in females of both groups: CONT-males 376.8 ± 6.4 vs. the CONT-females 250.4 ± 4.6 ("c", p ≤ 0.001); MEL-males 344.9 ± 7.3 vs. the MEL-females 230.0 ± 5.2 ("c", p ≤ 0.001). After 10 weeks of MEL treatment no changes in OGTTs, expressed as AUC (mmol.h), were recorded: MEL-males 14.28 ± 0.28 vs. the CONT-males 14.11 ± 0.29; MEL- females 14.41 ± 0.38 vs. the CONT-females 14.67 ± 0.74. The chronic (6 months lasting) MEL administration in males significantly decreased glucose concentration in serum and increased glycogen and triacylglycerols concentration/content in liver, cholesterol content in liver as well as glycogen content/concentration in heart muscle. In females only a significant increase of corticosterone concentration in serum and malondialdehyde concentration/content in liver was recorded (Tab. 3). MEL significantly increased liver weight and reduced thymus weight in males; in females no significant changes occurred (Tab. 4).
Six months lasting MEL treatment did not influence the epididymal fat weight in males and its body weight was not changed in comparison to controls (Tab. 4, Fig. 2 ). Body weight of MEL-females was significantly reduced from 18 th to 71 st day of the experiment, in the following period it came about the control levels (Fig. 2) ; periovarial fat weight in females was not influenced by MEL.
In MEL drinking females food and water intake did not differ from controls during the whole experiment.
In MEL-males food intake was temporary increased in the 14 th week and water intake in 10 th , 14 th and 18 th weeks of experiment (Tab. 5). The average daily food and water intake was higher in males in both groups than in females in both groups. The average daily MEL intake was 110.1 µg in females and 195.6 µg in males.
The average final body weight (g) in males of both groups was higher than in females of both groups: CONT-males 420.6 ± 10.5 vs. the CONT-females 270.1 ± 4.7 ("c", p ≤ 0.001); MEL-males 442.4 ± 12.8 vs. the MEL-females 276.2 ± 6.7 ("c", p ≤ 0.001). Twenty one weeks lasting MEL administration did not modify the course of OGTTs, expressed as AUC (mmol · h): MELmales 10.70 ± 0.35 vs. the CONT-males 11.21 ± 0.20; MEL-females 10.78 ± 0.16 vs. the CONT-females 11.50 ± 0.40.
Discussion
The effects of long-term melatonin treatment on physiological and metabolic parameters have not been sufficiently analyzed as yet, especially in young humans and experimental animals. MEL can induce some metabolic changes during sleep disorders and jet-lag syndrom treatment or as an adjuvant drug in oncological patients. As a next step after our previous studies of MEL administration (4 µg/mL) to young rat males and females of SD strain, with 3 (Marková et al., 2003) or 6 months (Marková et al., 2004) of MEL treatment, the same protocol for WH rats of both sexes was used in this study. Prolonged and chronical MEL administration reduced body weight in SD males that was accompanied by the decrease of epididymal fat tissue weight in males drinking MEL for 3 months. Similar results were recorded in this experiment when 3 months lasting MEL administration induced body weight decrease in both sexes of young WH rats associated with the epididymal fat weight decrease in males. The effect of 6 months lasting MEL treatment to the body weight was less pronounced in WH rats and was manifested only by its temporary decrease (till the half of experiment) in females, without a marked influence on the amount of ingested food in both sexes. MEL secretion decreases and visceral adiposity, as well as serum insulin and leptin values increase with the advanced age. MEL administration to the middle-aged male rats induces the return of these changes up to values of young animals and alleviates signs of age-induced metabolic syndrome to a certain degree (Rasmussen et al., 1999; . When MEL was administered to 10-month aged male SD rats fed high-fat diet in concentration 0.2 µg/mL during 8 weeks, the weight-gain was only half-valued in comparison with the controls not treated with MEL (Puchalski et al., 2003) . Wolden-Hanson et al., (2000) treated 10-month (middle-aged) male SD rats with MEL of 0.4 µg/mL concentration in tap water continuously for 12 weeks. Three months lasting MEL administration reduced the body weight, relative weight of intraabdominal fat as well as insulin and leptin levels. The locomotor activity, core body temperature and the morning corticosterone levels were increased up to values of control animals at the same time. The locomotor activity increase as a result of MEL ingestion could be the reason of body weight decrease in young rats in our experiment, suggested by corticosterone concentration rise in males after 3 months and in females after 6 months of MEL administration. Six months lasting MEL treatment induced the increase of corticosterone levels also in females of SD strain (Marková et al., 2004) . Another factor co-influencing on the body weight gain induced by MEL is leptin which acts as the inhibitor of food intake and enhances an energy release in mammals in cooperation with insulin (Williams et al., 2001) . A verification of regulatory effect of leptin requires following studies in these types of experiments. The analysis of MEL effect on the weight of organs revealed marked inter-sexual differences. The weights of organs were not influenced in MEL-treated WH females (with exception of the increase of relative weight of heart muscle after 6-month MEL administration). In males, 3 months lasting MEL treatment induced the increase of relative weight of heart muscle, spleen and adrenals; the chronic MEL application evoked the liver weight increase and the thymus weight decrease. The aforementioned changes differ from those found in the SD strain, where prolonged as well as chronic MEL administration in females caused the increase of periovarial fat weight accompanied by less-marked weight changes of the other studied organs (heart muscle weight increase after 3 months MEL administration and liver weight decrease after 6 months MEL treatment). The males of SD strain reacted more markedly to the prolonged MEL administration: the decrease of the weight of liver, heart muscle, adrenals and epididymal fat was recorded, while the chronic MEL administration caused the isolated decrease of liver weight (Marková et al., 2003; .
The data on MEL effect on variables of carbohydrate metabolism are not consistent. MEL administration increased glycemia in rats (Csaba & Barath, 1971) , whereas in other experiment glucose levels were not changed after MEL treatment (Bailey et al., 1974) or were decreased (Iizuka, 1996) . In Wistar strain male rats the pinealectomy increased the night glucose levels as well as its average daily concentration, however, it did not influence the daily serum insulin concentrations as compared to control animals. MEL administration to pinealectomized animals shifted the average daily glucose concentration to normal values, but did not restore its 24-hour rhythm (la Fleur et al., 2001) . MEL effect on glucose metabolism in our experiment was manifested by glycemia depression in females after 3 months lasting MEL treatment and also in males after 6 months MEL administration, without any changes in glucose tolerance. Serum insulin concentration in males and females after 3 months lasting MEL treatment was not changed; in animals chronically ingested MEL in the present experiment insulin levels were not determined. The decline of insulin levels was recorded in male SD rats chronically treated by MEL (Marková et al., 2004) .
Among the all experimental groups the most distinguished metabolic changes were seen in the males drinking MEL for 6 months. These changes could be associated with higher water intake in males as compared to females (i.e. higher amount of ingested MEL). It is known that pinealectomy has inhibitory effect on glycogenesis in rat liver and muscles, the infusions of pineal extracts being exhibiting a stimulating effect on glycogen synthesis (Milcu et al., 1971) . The increase of liver glycogen content, seen in chronically treated male rats by us, was observed also by Mazepa et al. (2000) in rats after MEL administration at higher doses (0.5 or 2.0 mg/kg).
Except of 6-month MEL treated males the increase of liver malondialdehyde was recorded. In SD strain the concentration of liver malondialdehyde was not affected by MEL (Marková et al., 2003; . Liver is the key site of MEL transformation to 6hydroxymelatonin; both these substances display the antioxidative effects, effectively scavenge free radicals and act oncostatically (for a review, see Reiter et al., 2003) . 6-Hydroxymelatonin was proved to have the in vitro prooxidative properties as well as it can induce the oxidative damage of DNA and thus may display procancerogenic properties (Sakano et al., 2004) . These observations should be taken into account at long-time MEL administration as a food supplement or as adjuvant drug.
Sexual dimorfism in metabolic response on prolonged or chronic MEL administration at low doses to young rats of WH strain was found: the changes of organ weights and reduction of fat tissue after 3 months lasting MEL treatment were recorded only in males (along with the increased serum corticosterone concentration). In females, the prolonged MEL administration decreased the glycemia. Chronic MEL administration to females increased the periovarial fat and heart muscle weights and serum corticosterone concentration. In males, the 6 months lasting MEL administration influenced more metabolic parameters than in females: decreased glycemia, increased liver and heart muscle glycogen concentration, increased triacylglycerols con-centration and cholesterol content in liver. The comparison of effects of low doses of MEL administered during long time (Marková et al., 2003) and chronically (Marková et al., 2004) to SD rats of both sexes with the present results in WH rats of both sexes indicate marked differences in reactivity of both strains. Besides inter-strain difference, higher reactivity of males to MEL treatment was registered which was associated with higher daily and total consumption of MEL.
The designed metabolic changes, especially in carbohydrate area, in both sexes of two strains of laboratory rat after long-term administration of exogenous melatonin restricted the possibility of this compound use in human medicine.
